| (210) | Number of the EPO application | 19739472 |
| (220) | Filing date of the EPO application | 2019.06.20 |
| (80) | EPO patent specification publication (B) | EPB nr. 30/2024, 2024.07.24 |
| (110) | EPO patent number | 3810281 |
| (21) | Number of the application | e 2021 0402 |
| (71) | Name(s) of applicant(s), code of the country | REGENERON PHARMACEUTICALS, INC., US; |
| (72) | Name(s) of inventor(s), code of the country | CRAWFORD Alison, US; |
| (73) | Name(s) of owner(s), code of the country | REGENERON PHARMACEUTICALS, INC., US; |
| (54) | Title of the invention | METHODS FOR TREATING CANCER WITH BISPECIFIC ANTI-CD3XMUC16 ANTIBODIES AND ANTI-PD-1 ANTIBODIES |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61P 35/00 (2006.01.01); C07K 16/28 (2006.01.01); C07K 16/30 (2006.01.01); A61K 39/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2021.05.31 |
| (30) | Priority | 201862688251 P, 2018.06.21, US |
| (86) | International application | PCT/US2019/038163, 2019.06.20 |
| (87) | International publication | WO 2019/246356, 2019.12.26 |